Clinical Trial Update: Multi-Center Feasibility Study of Trans-oral Endoscopic Restrictive Implant System (TERIS) for Treatment of Obesity [Phase 1]

View source ↗

Summary

A multi-center Phase 1 feasibility trial evaluating the Trans-oral Endoscopic Restrictive Implant System (TERIS) for obesity has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Trans-oral Endoscopic Restrictive Implant System (TERIS)

Snippet

Sponsor: BaroSense Inc. | Conditions: Obesity | Phase 1 | Status: COMPLETED